Literature DB >> 11230110

Activation of human neutrophil by cytokine-activated endothelial cells.

T Takahashi1, F Hato, T Yamane, H Fukumasu, K Suzuki, S Ogita, Y Nishizawa, S Kitagawa.   

Abstract

Cytokine activation of vascular endothelial cells renders the hyperadhesiveness for neutrophils. During the processes of inflammation and atherosclerosis, the production of reactive oxygen species by neutrophils contributes to endothelial cell (EC) damage and injury. However, the precise mechanisms for neutrophil activation by ECs remain unknown. Thus, we investigated what kinds of pathophysiological factors synthesized by inflammatory cytokine-activated ECs potentiated the activity of neutrophil functions. The magnitude of O(2)(-) release from neutrophils, which is one of pivotal neutrophil functions, was measured as an indicator potentiated by activated ECs. Neutrophils release massive amounts of O(2)(-) on coculture with activated ECs. Anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody (Ab) or specific platelet-activating factor (PAF)-receptor antagonist suppressed the O(2)(-) release from neutrophils on coculture with the activated ECs by 50% to 70%. The supernatants from activated ECs also induced O(2)(-) release by neutrophils. This stimulatory effect of activated EC supernatants on O(2)(-) release by neutrophils was abolished by anti-GM-CSF Ab or by PAF-receptor antagonist. As we previously reported, we demonstrated the expression of GM-CSF mRNA by Northern blotting and protein synthesis of GM-CSF by ELISA on tumor necrosis factor as well as interleukin-1-activated ECs. Although phosphorylation of mitogen-activated protein kinases was observed in ECs stimulated by tumor necrosis factor and interleukin-1, treatment of ECs with PD98059 (MEK1 inhibitor) and SB203580 (p38 mitogen-activated protein kinase inhibitor) in the presence of the cytokine failed to attenuate the stimulatory effect of activated ECs on neutrophil activation. We found that activated ECs regulated neutrophil function on coculture. We show here for the first time, to our knowledge, that the collaboration between GM-CSF and PAF synthesized by activated ECs markedly potentiated neutrophil activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230110     DOI: 10.1161/01.res.88.4.422

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  14 in total

1.  Divergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venules.

Authors:  R E Young; R D Thompson; S Nourshargh
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 2.  Regulation of neutrophil functions by proinflammatory cytokines.

Authors:  Takayuki Kato; Seiichi Kitagawa
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

3.  Endothelium-derived GM-CSF influences expression of oncostatin M.

Authors:  Wafa M Elbjeirami; Elizabeth M Donnachie; Alan R Burns; C Wayne Smith
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-20       Impact factor: 4.249

4.  Mechanism and effect of thrombospondin-4 polymorphisms on neutrophil function.

Authors:  Elzbieta Pluskota; Olga I Stenina; Irene Krukovets; Dorota Szpak; Eric J Topol; Edward F Plow
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

5.  Novel role for aldose reductase in mediating acute inflammatory responses in the lung.

Authors:  Thyyar M Ravindranath; Phyllus Y Mong; Radha Ananthakrishnan; Qing Li; Nosirudeen Quadri; Ann Marie Schmidt; Ravichandran Ramasamy; Qin Wang
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

6.  Serine protease inhibitors inhibit superoxide release and adherence in human neutrophils stimulated by granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha.

Authors:  Yue-Min Zhou; Haruo Kutsuna; Kenichi Suzuki; Fumihiko Hato; Seiichi Kitagawa
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

7.  Pathogenesis of atherosclerosis: A multifactorial process.

Authors:  Raja B Singh; Sushma A Mengi; Yan-Jun Xu; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002

8.  Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation.

Authors:  Ricky J Haywood-Watson; John B Holcomb; Ernest A Gonzalez; Zhanglong Peng; Shibani Pati; Pyong Woo Park; WeiWei Wang; Ana Maria Zaske; Tyler Menge; Rosemary A Kozar
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

9.  Protective effect of EDTA preadministration on renal ischemia.

Authors:  Chiara Foglieni; Alessandro Fulgenzi; Paolo Ticozzi; Fabio Pellegatta; Clara Sciorati; Daniela Belloni; Elisabetta Ferrero; Maria Elena Ferrero
Journal:  BMC Nephrol       Date:  2006-03-15       Impact factor: 2.388

10.  Endothelial CD36 Contributes to Postischemic Brain Injury by Promoting Neutrophil Activation via CSF3.

Authors:  Lidia Garcia-Bonilla; Gianfranco Racchumi; Michelle Murphy; Josef Anrather; Costantino Iadecola
Journal:  J Neurosci       Date:  2015-11-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.